BioXcel Therapeutics Inc. – Filings and Transcripts

NASDAQ: BTAI
Share price (7/2/26): $1.38
Market cap (7/2/26): $42.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Rodriguez Javier

Steinhart Richard I

News Filter

Material Definitive Agreement, Financial Statements or Exhibits

FDA Accepted sNDA for IGALMI® Use in At-Home (Outpatient) Setting; Set Nov. 14, 2026, as PDUFA Date

Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Reports Fourth Quarter and Full-Year 2025 Financial Results as Company Prepares for Potential IGALMI® Approval in Outpatient Setting

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness